NO20084577L - Probiotisk stamme og antimikrobielle peptider fra disse - Google Patents

Probiotisk stamme og antimikrobielle peptider fra disse

Info

Publication number: NO20084577L
Authority: NO; Norway
Prior art keywords: peptide; antimicrobial; strain; st4sa; mundtii
Prior art date: 2006-05-28

Application number

NO20084577A

Other languages

English (en)

Norwegian (no)

Inventor

Leon Milner Theodore Dicks

Svetoslav Dimitrov Todorov

Hendriette Knoetze

Marelize Brink

Original Assignee

Cipla Medpro Res And Dev Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-05-28

Filing date

2008-11-03

Publication date

2008-12-19

2006-05-28 Priority claimed from ZA200604035A external-priority patent/ZA200604035B/xx

2008-11-03 Application filed by Cipla Medpro Res And Dev Pty Ltd filed Critical Cipla Medpro Res And Dev Pty Ltd

2008-12-19 Publication of NO20084577L publication Critical patent/NO20084577L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Mycology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Dentistry (AREA)
Environmental Sciences (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20084577A 2006-05-28 2008-11-03 Probiotisk stamme og antimikrobielle peptider fra disse NO20084577L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ZA200604035A ZA200604035B (en)	2005-05-31	2006-05-28	Improved grenade launcher
PCT/IB2007/051982 WO2007138538A2 (fr)	2006-05-28	2007-05-25	Souche probiotique et peptide antimicrobien dérivé de ladite souche

Publications (1)

Publication Number	Publication Date
NO20084577L true NO20084577L (no)	2008-12-19

Family

ID=38779065

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20084577A NO20084577L (no)	2006-05-28	2008-11-03	Probiotisk stamme og antimikrobielle peptider fra disse

Country Status (13)

Country	Link
US (2)	US7951385B2 (fr)
EP (1)	EP2021457B1 (fr)
JP (1)	JP2009538614A (fr)
KR (1)	KR101521123B1 (fr)
CN (1)	CN101454440B (fr)
AP (1)	AP2841A (fr)
AU (1)	AU2007266675B2 (fr)
CA (1)	CA2647161A1 (fr)
EA (1)	EA017558B1 (fr)
IL (2)	IL195520A0 (fr)
NO (1)	NO20084577L (fr)
NZ (1)	NZ571619A (fr)
WO (1)	WO2007138538A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2007266675B2 (en) *	2006-05-28	2012-09-06	Cipla-Medpro (Pty) Ltd	Probiotic strain and antimicrobial peptide derived therefrom
US8357519B2 (en) *	2008-11-19	2013-01-22	The Ohio State University	Methods and processes for producing esters
WO2011045764A1 (fr) *	2009-10-15	2011-04-21	Cipla Medpro Research And Development (Pty) Ltd	Produit permettant d'administrer des substances actives antimicrobiennes à un site infecté
WO2012060312A1 (fr) *	2010-11-05	2012-05-10	国立大学法人広島大学	Bactérie lactique végétale isolée à partir de balles de riz ou de riz cargo et utilisation de celle-ci
WO2012148891A1 (fr) *	2011-04-29	2012-11-01	Evonik Degussa Corporation	Conjugués peptide-lipide et leurs utilisations
RU2532227C1 (ru) *	2013-10-23	2014-10-27	Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ)	Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью
RU2599430C1 (ru) *	2015-07-23	2016-10-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет"	ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ
US9944960B2 (en) *	2015-11-17	2018-04-17	Premier Research Labs, Lp	Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils
CN105385636A (zh) *	2015-12-07	2016-03-09	江南大学	一株产细菌素的肠膜明串珠菌及其应用
WO2017173240A1 (fr)	2016-03-31	2017-10-05	Gojo Industries, Inc.	Composition nettoyante stimulant les peptides antimicrobiens
JP2019510036A (ja)	2016-03-31	2019-04-11	ゴジョ・インダストリーズ・インコーポレイテッド	プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
KR101722255B1 (ko) *	2016-04-22	2017-04-03	주식회사 폴인브레드	쌀과 쌀누룩을 이용한 자연발효종 제조방법
EP3544575A1 (fr)	2016-11-23	2019-10-02	GOJO Industries, Inc.	Composition désinfectante comprenant une substance active probiotique/prébiotique
KR102748132B1 (ko) *	2017-09-19	2025-01-02	어드박시스, 인크.	박테리아 또는 리스테리아 균주의 동결건조를 위한 조성물 및 방법
US11911420B2 (en)	2018-01-31	2024-02-27	Nutri Co., Ltd.	Prophylactic and/or therapeutic agents for Streptococcus pneumoniae infection
KR102076089B1 (ko)	2018-10-02	2020-02-11	서울대학교 산학협력단	니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp)
CN109456911B (zh) *	2018-10-10	2019-10-18	南京林业大学	一株蒙氏肠球菌HcM7及其应用
CN110846260B (zh) *	2019-12-18	2021-03-02	江南大学	一株降低生物胺的肉葡萄球菌及其应用
KR20240115407A (ko) *	2023-01-18	2024-07-26	조선대학교산학협력단	오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH1084969A (ja)	1996-09-19	1998-04-07	Chemo Sero Therapeut Res Inst	ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
US7655775B2 (en) *	1997-09-05	2010-02-02	Canbiocin, Inc.	Expression vectors for treating bacterial infections
AU7898700A (en)	1999-10-22	2001-05-08	Shanghai Bio Road Gene Development Ltd.	A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
GB0027761D0 (en)	2000-11-14	2000-12-27	Nestle Sa	Nutritional composition for an immune condition
DE10105347A1 (de) *	2001-02-05	2002-08-22	Nutrinova Gmbh	Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
GB0125535D0 (en)	2001-10-24	2001-12-12	Microbiological Res Authority	Mycobacterial genes down-regulated during latency
US6878373B2 (en)	2001-12-03	2005-04-12	Micropure Technologies, Inc.	Probiotic composition containing Bacillus cereus RRRL B-30535
JP4111489B2 (ja)	2002-05-23	2008-07-02	プリマハム株式会社	新規バクテリオシン
AU2003211648A1 (en) *	2002-07-03	2004-01-23	Galina Gennadievna Alekhina	Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof
EP1384483A1 (fr)	2002-07-23	2004-01-28	Nestec S.A.	Microorganismes probiotiques pour le traitement du syndrome du colon irritabile par l'amélioration de la fonction neuro-musculaire de l'intestin
ITBO20020564A1 (it)	2002-09-06	2004-03-07	Alfa Wassermann Spa	Bifidobatteri e preparazioni che li contengono.
AU2007266675B2 (en) *	2006-05-28	2012-09-06	Cipla-Medpro (Pty) Ltd	Probiotic strain and antimicrobial peptide derived therefrom

2007
- 2007-05-25 AU AU2007266675A patent/AU2007266675B2/en not_active Ceased
- 2007-05-25 JP JP2009512739A patent/JP2009538614A/ja active Pending
- 2007-05-25 EP EP07736018.8A patent/EP2021457B1/fr active Active
- 2007-05-25 EA EA200802409A patent/EA017558B1/ru not_active IP Right Cessation
- 2007-05-25 CN CN2007800198580A patent/CN101454440B/zh not_active Expired - Fee Related
- 2007-05-25 KR KR1020087031307A patent/KR101521123B1/ko not_active Expired - Fee Related
- 2007-05-25 AP AP2008004626A patent/AP2841A/xx active
- 2007-05-25 WO PCT/IB2007/051982 patent/WO2007138538A2/fr not_active Ceased
- 2007-05-25 CA CA002647161A patent/CA2647161A1/fr not_active Abandoned
- 2007-05-25 NZ NZ571619A patent/NZ571619A/en not_active IP Right Cessation
- 2007-05-25 US US12/302,067 patent/US7951385B2/en active Active
2008
- 2008-11-03 NO NO20084577A patent/NO20084577L/no not_active Application Discontinuation
- 2008-11-26 IL IL195520A patent/IL195520A0/en unknown
2011
- 2011-04-26 US US13/094,155 patent/US8444998B2/en not_active Expired - Fee Related
2017
- 2017-02-16 IL IL250634A patent/IL250634A0/en unknown

Also Published As

Publication number	Publication date
CN101454440B (zh)	2013-05-29
EA200802409A1 (ru)	2009-10-30
EP2021457A2 (fr)	2009-02-11
US8444998B2 (en)	2013-05-21
IL195520A0 (en)	2011-08-01
AP2008004626A0 (en)	2008-10-31
KR20090023626A (ko)	2009-03-05
EP2021457B1 (fr)	2015-02-11
AP2841A (en)	2014-02-28
WO2007138538A2 (fr)	2007-12-06
CA2647161A1 (fr)	2007-12-06
AU2007266675A1 (en)	2007-12-06
AU2007266675B2 (en)	2012-09-06
US7951385B2 (en)	2011-05-31
KR101521123B1 (ko)	2015-05-19
US20090297482A1 (en)	2009-12-03
WO2007138538A3 (fr)	2008-04-17
EA017558B1 (ru)	2013-01-30
CN101454440A (zh)	2009-06-10
NZ571619A (en)	2011-10-28
JP2009538614A (ja)	2009-11-12
US20110268703A1 (en)	2011-11-03
IL250634A0 (en)	2017-03-30

Publication	Publication Date	Title
NO20084577L (no)	2008-12-19	Probiotisk stamme og antimikrobielle peptider fra disse
Shih et al.	2005	Selective production and characterization of levan by Bacillus subtilis (Natto) Takahashi
Peltier et al.	2008	Recent knowledge and innovations related to hexofuranosides: structure, synthesis and applications
WO2010093627A3 (fr)	2010-10-14	Compositions supports à base du domaine de la fibronectine de type iii, procédés et utilisations
CL2018000537A1 (es)	2018-07-20	Anticuerpo anti-factor d del complemento; polinucleótido codificante; vector que comprende dicho polinucleótido; célula húesped que comprende dicho vector; método de fabricación de anticuerpo; composición farmacéutica que lo comprende; uso del anticuerpo para tratar trastornos inflamatorios o trastornos oculares (divisional de cl 1001-2009).
AR064216A1 (es)	2009-03-18	Polipeptidos cristalinos de bacillus thuringiensis, polinucleotidos y composiciones de los mismos
AR070058A1 (es)	2010-03-10	Enzima bacteriana asociada con la sintesis de ecuol
NO20080745L (no)	2008-04-09	Nye peptider for anvendelse i behandling av fedme
NO20062662L (no)	2006-08-07	Muteiner av fibroblast vekstfaktor 21
MX2009011198A (es)	2009-10-30	Peliculas que comprenden una pluralidad de polimeros.
NO20092331L (no)	2009-06-17	LINGO-bindingsmolekyler og farmasoytisk anvendelse derav
MX2009004969A (es)	2009-05-21	Acido hialuronico reticulado y su metodo de produccion.
BR112012033703A2 (pt)	2016-10-11	polipeptídeo tendo atividade beta-glicosidase e seus usos
Lee et al.	2020	Why?–Successful Pseudomonas aeruginosa clones with a focus on clone C
BR112012033714A2 (pt)	2016-02-16	polipeptídeo com atividade de acetil xilano esterase e seus usos.
BR0309570A (pt)	2005-02-22	Fatores camp quiméricos para vacinação contra infecção por streptococcus
BR112012033701A2 (pt)	2018-08-28	polipeptídeo tendo atividade de degradação de carbohidrato e seus usos
DK2040560T3 (da)	2010-08-16	Cysteingranuler og anvendelse deraf som bifidobacterium animalis lactis vækststimulanter
Von Ossowski	2017	Novel molecular insights about lactobacillar sortase-dependent piliation
Kowalewska et al.	2024	Synergistic self-healing enhancement in multifunctional silicone elastomers and their application in smart materials
BRPI0516946A (pt)	2008-09-23	enzimas lacase e seus usos
Kriaa et al.	2021	SP-1, a serine protease from the gut microbiota, influences colitis and drives intestinal dysbiosis in mice
Mazilu et al.	2021	Preparation and in vitro characterization of gels based on bromelain, whey and quince extract
BR112012012915A2 (pt)	2015-09-29	bactéria pertencente à família enterobacteriaceae, e, método para produção de l-cisteína, l-cistina, um derivado das mesmas, ou uma mistura das mesmas
BR112012033396A2 (pt)	2015-06-23	Polipetídeo tendo atividade swollenin e seus usos.

Legal Events

Date	Code	Title	Description
2015-09-07	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: CIPLA-MEDPRO (PTY) LTD., ZA
2019-12-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application